AMPK Activation Restores Salivary Function Following Radiation Treatment.

Area of Science:

• Oncology
• Molecular Biology
• Radiotherapy Research

Background:

• Head and neck cancers are a significant global health concern.
• Radiotherapy for these cancers often causes severe, chronic salivary gland dysfunction.
• Current treatments for radiation-induced salivary damage are palliative and lack efficacy.

Purpose of the Study:

• To investigate the role of adenosine monophosphate (AMP)-activated protein kinase (AMPK) in radiation-induced salivary gland damage.
• To evaluate the therapeutic potential of AMPK activators in mitigating this damage.

Main Methods:

• Irradiation (IR) of salivary glands and assessment of AMPK pathway markers.
• Administration of AMPK activators (AICAR and metformin) post-IR.
• Evaluation of salivary gland function, compensatory proliferation, polarity, and differentiation markers.

Main Results:

• IR decreased phosphorylated AMPK, NAD+, and AMP, while increasing ATP.
• AMPK activators (AICAR, metformin) attenuated compensatory proliferation and reversed chronic salivary dysfunction.
• AMPK activators restored markers of polarity and differentiation in irradiated parotid glands.

Conclusions:

• AMPK pathway is dysregulated by IR in salivary glands.
• AMPK activation represents a potential therapeutic strategy for radiation-induced salivary damage.
• Targeting AMPK may offer a novel treatment for xerostomia and related complications.